4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001830755-25-000005
Chief Medical Officer sold 10,000 shares at $20.00 ($200,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hamilton James C · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-13 | Sale : show line 1 in the form 10b5-1 | −611 | $20.00 | $12,220 | 271,511 | D |
| 2025-08-15 | Sale : show line 2 in the form 10b5-1 | −9,389 | $20.00 | $187,780 | 262,122 | D |
| Open-market sales · 10,000 sh · avg $20.00 · $200,000 | ||||||
Loading xslF345X05/wk-form4_1755295139.xml…